Stockreport

Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus [Yahoo! Finance]

Personalis, Inc.  (PSNL) 
Last personalis, inc. earnings: 3/25 04:01 pm Check Earnings Report
PDF today the commencement of commercialization efforts by Tempus for NeXT Personal® , Personalis' ultra-sensitive, whole genome-based liquid biopsy assay for detection of m [Read more]